Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Kerr

Showing results (281-290 of 315) with videos related to

Pageof 32
Sort By:
The Lancet. Gastroenterology & Hepatology|July 26, 2018
Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based seriesEnric Domingo, Carme Camps, Pamela J Kaisaki, et al.
Nature Genetics|October 16, 2007
A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer riskPeter Broderick, Luis Carvajal-Carmona, Alan M Pittman, et al.
Nature Genetics|December 18, 2007
Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer riskEmma Jaeger, Emily Webb, Kimberley Howarth, et al.
Journal of Diabetes Science and Technology|May 30, 2025
The Use of Continuous Glucose Monitoring to Diagnose Stage 2 Type 1 DiabetesJulia K Mader, Jenise C Wong, Guido Freckmann, et al.
FEBS Open Bio|February 12, 2026
Applicability of mitotic figure counting by deep learning: a development and pan-cancer validation studyJoakim Kalsnes, Maria X Isaksen, Frida Julbø, et al.
British Journal of Cancer|January 15, 2024
Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysisGwénaël Le Teuff, Nathalie Cozic, Jean-Christophe Boyer, et al.
Therapeutic Advances in Musculoskeletal Disease|March 30, 2026
The protocol for a patient-driven online prospective European observational cohort aiming to determine risk factors for the development of psoriatic arthritis among people living with psoriasis: the HIPPOCRATES Prospective Observational StudyTeresa Grohmann, Timeo Mtenga, David Kerr, et al.
Gut|November 1, 2024
Pharmacological activation of STAT1-GSDME pyroptotic circuitry reinforces epigenetic immunotherapy for hepatocellular carcinomaYalin Tu, Haoran Wu, Chengpeng Zhong, et al.
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker studyEnric Domingo, Luke Freeman-Mills, Emily Rayner, et al.
Scientific Reports|August 4, 2015
Erratum: A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancerNada A Al-Tassan, Nicola Whiffin, Fay J Hosking, et al.
Pageof 32

Showing results (281-290 of 315) with videos related to

Sort By:
Pageof 32
The Lancet. Gastroenterology & Hepatology|July 26, 2018
Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based seriesEnric Domingo, Carme Camps, Pamela J Kaisaki, et al.
Nature Genetics|October 16, 2007
A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer riskPeter Broderick, Luis Carvajal-Carmona, Alan M Pittman, et al.
Nature Genetics|December 18, 2007
Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer riskEmma Jaeger, Emily Webb, Kimberley Howarth, et al.
Journal of Diabetes Science and Technology|May 30, 2025
The Use of Continuous Glucose Monitoring to Diagnose Stage 2 Type 1 DiabetesJulia K Mader, Jenise C Wong, Guido Freckmann, et al.
FEBS Open Bio|February 12, 2026
Applicability of mitotic figure counting by deep learning: a development and pan-cancer validation studyJoakim Kalsnes, Maria X Isaksen, Frida Julbø, et al.
British Journal of Cancer|January 15, 2024
Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysisGwénaël Le Teuff, Nathalie Cozic, Jean-Christophe Boyer, et al.
Therapeutic Advances in Musculoskeletal Disease|March 30, 2026
The protocol for a patient-driven online prospective European observational cohort aiming to determine risk factors for the development of psoriatic arthritis among people living with psoriasis: the HIPPOCRATES Prospective Observational StudyTeresa Grohmann, Timeo Mtenga, David Kerr, et al.
Gut|November 1, 2024
Pharmacological activation of STAT1-GSDME pyroptotic circuitry reinforces epigenetic immunotherapy for hepatocellular carcinomaYalin Tu, Haoran Wu, Chengpeng Zhong, et al.
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker studyEnric Domingo, Luke Freeman-Mills, Emily Rayner, et al.
Scientific Reports|August 4, 2015
Erratum: A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancerNada A Al-Tassan, Nicola Whiffin, Fay J Hosking, et al.
Pageof 32